Display options
Share it on

Diabet Med. 2021 Oct 01;e14704. doi: 10.1111/dme.14704. Epub 2021 Oct 01.

Sexual dysfunction in women with type 1 diabetes in Norway: A cross-sectional study on the prevalence and associations with physical and psychosocial complications.

Diabetic medicine : a journal of the British Diabetic Association

Anne Haugstvedt, Jannike Jørgensen, Ragnhild B Strandberg, Roy M Nilsen, Jakob F Haugstvedt, Rodica Pop-Busui, Eirik Søfteland

Affiliations

  1. Faculty of Health and Social Sciences, Western Norway University of Applied Sciences, Bergen, Norway.
  2. Department of Medicine, Haukeland University Hospital, Bergen, Norway.
  3. Department of Medicine, Haraldsplass Hospital, Bergen, Norway.
  4. Division of Metabolism, Endocrinology & Diabetes, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
  5. Hormone Laboratory, Haukeland University Hospital, Bergen, Norway.
  6. Faculty of Medicine, University of Bergen, Norway.

PMID: 34596251 DOI: 10.1111/dme.14704

Abstract

AIM: To estimate the prevalence of sexual dysfunction in women with type 1 diabetes (T1D) compared with women without diabetes and to analyse associations between sexual dysfunction and the presence of chronic physical diabetes complications, diabetes distress and depression in women with T1D.

METHODS: This cross-sectional study was conducted in Norway, and 171 women with T1D and 60 controls completed the Female Sexual Function Index (FSFI) and the Hospital Anxiety and Depression Scale (HADS). Diabetes distress was assessed with the Problem Areas in Diabetes (PAID) scale. Data on diabetes complications were retrieved from medical records. We performed logistic regression to estimate differences in the prevalence of sexual dysfunction (defined as FSFI ≤26.55) between women with T1D and women without diabetes and to examine associations of sexual dysfunction with chronic diabetes complications, diabetes distress and depression in women with T1D.

RESULTS: The prevalence of sexual dysfunction was higher in women with T1D (50.3%) compared with the controls (35.0%; unadjusted odds ratio [OR] 1.89 [95% confidence interval (CI) 1.06-3.37]; adjusted OR 1.93 [1.05-3.56]). In women with T1D, sexual dysfunction was associated with both diabetes distress (adjusted OR 1.03 [1.01-1.05]) and depression (adjusted OR 1.28 [1.12-1.46]), but there were no clear associations with chronic diabetes complications (adjusted OR 1.46 [0.67-3.19]).

CONCLUSIONS: This study suggests that sexual dysfunction is more prevalent in women with T1D compared with women without diabetes. The study findings emphasize the importance of including sexual health in relation to diabetes distress and psychological aspects in diabetes care and future research.

© 2021 The Authors. Diabetic Medicine published by John Wiley & Sons Ltd on behalf of Diabetes UK.

Keywords: female sexual dysfunction; type 1 diabetes

References

  1. Katsarou A, Gudbjörnsdottir S, Rawshani A, et al. Type 1 diabetes mellitus. Nat Rev Dis Prim. 2017;3(1):1-17. - PubMed
  2. Association AD. 5. Facilitating behavior change and well-being to improve health outcomes: standards of medical care in diabetes-2021. Diabetes Care. 2021;44(Supplement 1):S53-S72. - PubMed
  3. Fisher L, Polonsky WH, Hessler D. Addressing diabetes distress in clinical care: a practical guide. Diab Med. 2019;36(7):803-812. - PubMed
  4. Pouwer F, Schram M, Iversen M, Nouwen A, Holt R. How 25 years of psychosocial research has contributed to a better understanding of the links between depression and diabetes. Diab Med. 2020;37(3):383-392. - PubMed
  5. Enzlin P, Rosen R, Wiegel M, et al. Sexual dysfunction in women with type 1 diabetes: long-term findings from the DCCT/EDIC study cohort. Diabetes Care. 2009;32(5):780-785. - PubMed
  6. Pontiroli AE, Cortelazzi D, Morabito A. Female sexual dysfunction and diabetes: a systematic review and meta-analysis. J Sex Med. 2013;10(4):1044-1051. - PubMed
  7. Mazzilli F, Mazzilli R, Imbrogno N, et al. Sexual dysfunction in diabetic women: prevalence and differences in type 1 and type 2 diabetes mellitus. Diabetes Metab Syndr Obes. 2015;8:97. - PubMed
  8. Wessells H, Braffett BH, Holt SK, et al. Burden of urological complications in men and women with long-standing type 1 diabetes in the diabetes control and complications trial/epidemiology of diabetes interventions and complications cohort. Diabetes Care. 2018;41(10):2170-2177. - PubMed
  9. Flotynska J, Uruska A, Michalska A, Araszkiewicz A, Zozulinska-Ziolkiewicz D. Sexual dysfunction is a more common problem in young women with type 1 diabetes than in healthy women. J Sex Marital Ther. 2019;45(7):643-651. - PubMed
  10. Zamponi V, Mazzilli R, Bitterman O, et al. Association between type 1 diabetes and female sexual dysfunction. BMC Women's Health. 2020;20:1-7. - PubMed
  11. Hotaling JM, Sarma AV, Patel DP, et al. Cardiovascular autonomic neuropathy, sexual dysfunction, and urinary incontinence in women with type 1 diabetes. Diabetes Care. 2016;39(9):1587-1593. - PubMed
  12. Braffett BH, Wessells H, Sarma AV. Urogenital autonomic dysfunction in diabetes. Curr Diab Rep. 2016;16(12):119. - PubMed
  13. Bitzer J, Alder J. Diabetes and female sexual health. Women’s Health. 2009;5(6):629-636. - PubMed
  14. Rosen CB, Heiman J, Leiblum S, et al. The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther. 2000;26(2):191-208. - PubMed
  15. Wiegel M, Meston C, Rosen R. The female sexual function index (FSFI): cross-validation and development of clinical cutoff scores. J Sex Marital Ther. 2005;31(1):1-20. - PubMed
  16. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361-370. - PubMed
  17. Snaith RP. The hospital anxiety and depression scale. Health Qual Life Outcomes. 2003;1(1):1-4. - PubMed
  18. Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale: an updated literature review. J Psychosomat Res. 2002;52(2):69-77. - PubMed
  19. Mykletun A, Stordal E, Dahl AA. Hospital Anxiety and Depression (HAD) scale: factor structure, item analyses and internal consistency in a large population. Br J Psychiatry. 2001;179(6):540-544. - PubMed
  20. Polonsky WH, Anderson BJ, Lohrer PA, et al. Assessment of diabetes-related distress. Diabetes Care. 1995;18(6):754-760. - PubMed
  21. Welch G, Weinger K, Anderson B, Polonsky WH. Responsiveness of the Problem Areas In Diabetes (PAID) questionnaire. Diab Med. 2003;20(1):69-72. - PubMed
  22. Welch G, Jacobson AM, Polonsky WH. The Problem Areas in Diabetes Scale. An evaluation of its clinical utility. Diabetes Care. 1997;20(5):760-766. - PubMed
  23. Althof SE, Rosen RC, Rogatis LD, Corty E, Quirk F, Symonds T. Outcome measurement in female sexual dysfunction clinical trials. J Sex Marital Ther. 2005;31(2):153-166. - PubMed
  24. Snoek FJ, Kersch NYA, Eldrup E, et al. Monitoring of Individual Needs in Diabetes (MIND)-2: follow-up data from the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) MIND study. Diabetes Care. 2012;35(11):2128-2132. - PubMed
  25. Haugstvedt A, Hernar I, Strandberg RB, et al. Use of patient-reported outcome measures (PROMs) in clinical diabetes consultations: study protocol for the DiaPROM randomised controlled trial pilot study. BMJ Open. 2019;9(1):e024008. - PubMed
  26. Hernar I, Graue M, Richards DA, et al. Use of patient-reported outcome measures (PROMs) in clinical diabetes consultations: the DiaPROM randomised controlled pilot trial. BMJ Open. 2021;11(4):e042353. - PubMed
  27. Haugstvedt A, Hernar I, Graue M, et al. Nurses’ and physicians’ experiences with diabetes consultations and the use of dialogue tools in the DiaPROM pilot trial: a qualitative study. Diab Med. 2021;38(6):e14419. - PubMed
  28. Løvaas KF, Madsen TV, Ueland GÅ, Sandberg S, Cooper JG. The Norwegian Diabets Register for Adults (NDR-A) - Annual report 2019. Noklus; 2020. - PubMed

Publication Types

Grant support